Work

Southwest Oncology Group Phase II Trial (S0341) of Erlotinib (OSI-774) in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2

Year: 2008
Type: article
Study design: Clinical Trial
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2041035291
FWCI: 5.209
Cites: 42
Cited by: 39
Related to: 10